J Korean Soc Menopause.  2011 Dec;17(3):142-149. 10.6118/jksm.2011.17.3.142.

The Survey on Korean Menopausal Women's Behavior and Perception of Hormone Therapy

• Namkung J
• Chung YJ
• Ha JE
• Jo HH
• Kim EJ
• Kwon DJ
• Lew YO
• Kim JH
• Kim MR

• KMID: 1444802
• DOI: http://doi.org/10.6118/jksm.2011.17.3.142

Abstract

OBJECTIVES
After Women's Health Initiative (WHI) study had been published, the use of hormone therapy (HT) have been decreasing even though it is the most effective therapy for menopausal symptom. The survey was conducted to investigate Korean menopausal women's perception of HT and behavior when they are treated by HT.
METHODS
During 4 weeks from September 2009 to October 2009, total 600 women aged 45~64 participated in the survey by face to face interview. Out of answering women, women who have visited clinic/hospital at least 1 time to treat their menopausal symptom during last 1 year were included. One hundred fifty women for each age group, 45~49, 50~54, 55~59 and 60~64, were recruited in consecutive order.
RESULTS
Eighty percent women who have visited clinic/hospital to treat menopausal symptom, visited obstetrics and gynecology. Only 16% of these women were current user, and other 84% of these women had no experience of HT (53%) or stopped therapy (31%). Among current user, only 9% of women have used HT more than 5 years. Eighty percent of current user had used HT less than 2 years. Most distressing menopausal symptom is 'hot flush' regardless HT experience. When doctor recommend HT, 72% of patients accept HT in overall. Among women who had no experience of HT, the most common reason of not to take HT was concern of side effects (51%). And 67% of women who had concern of side effects worried about cancer incidence.
CONCLUSION
Many women with menopausal symptom do not take HT even though it is the most effective therapy. Most of women who take HT stop treatment within 1 year. Most common reason of not to take HT is concern about side effect, increasing incidence of cancer related to HT. Therefore, HT should be considered to short-term relief of menopausal symptoms and at the minimal dose, if possible.

Keyword

Hormone therapy; Menopause; Perception

MeSH Terms

Aged
Female
Gynecology
Humans
Incidence
Menopause
Obstetrics
Women's Health

Reference

1. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004. 291:47–53.

2. The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010. 17:242–255.

3. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003. 362:419–427.

4. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause. 2008. 15:584–602.

5. Kim JG, Kim JW, Kim SH, Choi YM, Shin CJ, Moon SY, et al. A survey of menopausal women's attitudes on menopause and hormone replacement therapy. J Korean Soc Menopause. 1995. 1:42–50.

6. Sassarini J, Lumsden MA. Hot flushes: are there effective alternatives to estrogen? Menopause Int. 2010. 16:81–88.

7. Baumgartner AK, Hausler A, Seifert-Klauss V, Schuster T, Schwarz-Boeger U, Kiechle M. Breast cancer after hormone replacement therapy-does prognosis differ in perimenopausal and postmenopausal women? Breast. 2011. 20:448–454.

8. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007. 297:1465–1477.

9. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2009. 16:639–643.

10. Newton KM, Lacroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. The physician's role in women's decision making about hormone replacement therapy. Obstet Gynecol. 1998. 92:580–584.

11. Newton KM, Reed SD, Grothaus LC, La Croix AZ, Nekhlyudov L, Ehrlich K, et al. Hormone therapy discontinuation: physician practices after the Women's Health Initiative. Menopause. 2010. 17:734–740.